162 related articles for article (PubMed ID: 26313695)
1. Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology.
Polytarchou C; Oikonomopoulos A; Mahurkar S; Touroutoglou A; Koukos G; Hommes DW; Iliopoulos D
Inflamm Bowel Dis; 2015 Nov; 21(11):2533-9. PubMed ID: 26313695
[TBL] [Abstract][Full Text] [Related]
2. Identification of Circulating MicroRNA Signatures in Crohn's Disease Using the Nanostring nCounter Technology.
Oikonomopoulos A; Polytarchou C; Joshi S; Hommes DW; Iliopoulos D
Inflamm Bowel Dis; 2016 Sep; 22(9):2063-9. PubMed ID: 27542126
[TBL] [Abstract][Full Text] [Related]
3. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA in inflammatory bowel disease.
Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
[TBL] [Abstract][Full Text] [Related]
5. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
[TBL] [Abstract][Full Text] [Related]
6. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium.
Koukos G; Polytarchou C; Kaplan JL; Oikonomopoulos A; Ziring D; Hommes DW; Wahed R; Kokkotou E; Pothoulakis C; Winter HS; Iliopoulos D
Inflamm Bowel Dis; 2015 May; 21(5):996-1005. PubMed ID: 25738378
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
8. Peripheral Blood miR-148 Serves as a Novel Biomarker in Ulcerative Colitis Patients.
Ji Q; Li Y
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538061
[TBL] [Abstract][Full Text] [Related]
9. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.
Soendergaard C; Nielsen OH; Seidelin JB; Kvist PH; Bjerrum JT
Inflamm Bowel Dis; 2015 May; 21(5):1077-88. PubMed ID: 25803506
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative Colitis.
Netz U; Carter J; Eichenberger MR; Feagins K; Galbraith NJ; Dryden GW; Pan J; Rai SN; Galandiuk S
Inflamm Bowel Dis; 2017 Dec; 24(1):159-165. PubMed ID: 29272478
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.
Chen P; Li Y; Li L; Yu Q; Chao K; Zhou G; Qiu Y; Feng R; Huang S; He Y; Chen B; Chen M; Zeng Z; Zhang S
Aliment Pharmacol Ther; 2019 Mar; 49(6):733-743. PubMed ID: 30734320
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.
Krissansen GW; Yang Y; McQueen FM; Leung E; Peek D; Chan YC; Print C; Dalbeth N; Williams M; Fraser AG
Inflamm Bowel Dis; 2015 Mar; 21(3):520-30. PubMed ID: 25628040
[TBL] [Abstract][Full Text] [Related]
14. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
[TBL] [Abstract][Full Text] [Related]
16. Site-Specific MicroRNA Expression May Lead to Different Subtypes in Ulcerative Colitis.
Ranjha R; Aggarwal S; Bopanna S; Ahuja V; Paul J
PLoS One; 2015; 10(11):e0142869. PubMed ID: 26569605
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis.
Duttagupta R; DiRienzo S; Jiang R; Bowers J; Gollub J; Kao J; Kearney K; Rudolph D; Dawany NB; Showe MK; Stamato T; Getts RC; Jones KW
PLoS One; 2012; 7(2):e31241. PubMed ID: 22359580
[TBL] [Abstract][Full Text] [Related]
19. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
20. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
